Published in Diabetologia on May 01, 2012
UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia (2013) 1.46
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus. J Am Heart Assoc (2012) 0.92
Molecular and Electrophysiological Mechanisms Underlying Cardiac Arrhythmogenesis in Diabetes Mellitus. J Diabetes Res (2016) 0.91
Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. J Physiol (2016) 0.89
Sinoatrial node dysfunction induces cardiac arrhythmias in diabetic mice. Cardiovasc Diabetol (2014) 0.81
Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial. Cardiovasc Diabetol (2014) 0.81
Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort. Diabetes Care (2012) 0.78
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate. Cardiovasc Diabetol (2017) 0.76
Differential impact of type-1 and type-2 diabetes on control of heart rate in mice. Auton Neurosci (2015) 0.75
Effect of Resting Heart Rate on All-Cause Mortality and Cardiovascular Events According to Age. J Am Geriatr Soc (2016) 0.75
Cumulative Resting Heart Rate Exposure and Risk of All-Cause Mortality: Results from the Kailuan Cohort Study. Sci Rep (2017) 0.75
Cardiovascular autonomic neuropathy in patients with type 2 diabetes. J Diabetes Investig (2015) 0.75
The Effect of Resting Heart Rate on the New Onset of Microalbuminuria in Patients With Type 2 Diabetes: A Subanalysis of the ROADMAP Study. Medicine (Baltimore) (2016) 0.75
Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients. J Diabetes Res (2015) 0.75
A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus. Diabetes Obes Metab (2017) 0.75
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet (2010) 8.17
Diabetic autonomic neuropathy. Diabetes Care (2003) 6.59
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet (2008) 5.03
Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med (2005) 4.85
Competing risk regression models for epidemiologic data. Am J Epidemiol (2009) 4.75
Resting heart rate in cardiovascular disease. J Am Coll Cardiol (2007) 4.14
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J (2005) 4.06
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest (1991) 3.49
Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation. Diabetologia (2001) 3.33
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care (2003) 3.18
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet (2010) 2.80
Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol (1980) 2.62
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). J Am Coll Cardiol (2009) 2.19
The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia (2000) 1.86
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J (2009) 1.79
Assessing cardiorespiratory fitness without performing exercise testing. Am J Prev Med (2005) 1.73
Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.70
High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62
Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation (2003) 1.61
Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens (1997) 1.41
Heart rate as a predictor of mortality: the MATISS project. Am J Public Health (2001) 1.39
Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation (2001) 1.37
Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care (2003) 1.35
Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation (1997) 1.34
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol (1986) 1.33
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications (1992) 1.27
The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J (1997) 1.15
QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia (2006) 1.09
Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am J Physiol (1990) 1.06
J-shaped relationship between resting pulse rate and all-cause mortality in community-dwelling older people with disabilities. J Am Geriatr Soc (2008) 0.98
Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J Diabetes Complications (2003) 0.96
Heart rate and mortality in a Japanese general population: an 18-year follow-up study. J Clin Epidemiol (2001) 0.95
Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes (2003) 0.93
Elevated heart rate in cardiovascular diseases: a target for treatment? Prog Cardiovasc Dis (2009) 0.92
Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care (1996) 0.89
Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the euro heart survey on diabetes and the heart. Eur Heart J (2010) 0.89
The physiological determinants and risk correlations of elevated heart rate. Am J Hypertens (1999) 0.85
Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients. Diabetes Care (1992) 0.80
British Hypertension Society guidelines for hypertension management 1999: summary. BMJ (1999) 8.80
The "beta-like-globin" gene domain in human erythroid cells. Proc Natl Acad Sci U S A (1985) 8.35
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens (2004) 8.32
The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol (1999) 7.89
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia (2012) 7.19
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol (1995) 5.67
Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 5.63
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A (2000) 5.36
Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature (1981) 5.00
Membrane compartmentation is required for efficient T cell activation. Immunity (1998) 5.00
Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys (1999) 4.72
Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol (2004) 4.67
Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell (2001) 4.61
Geographical variations in senile osteoporosis. The association with physical activity. J Bone Joint Surg Br (1970) 4.56
Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res (1998) 4.39
Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci U S A (1992) 4.38
The frequency of uterine leiomyomas. Am J Clin Pathol (1990) 4.00
Higher cigarette prices influence cigarette purchase patterns. Tob Control (2005) 3.98
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem (2000) 3.74
Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens (2003) 3.67
ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol (2001) 3.55
Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 3.53
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res (1999) 3.48
Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. J Cell Biol (2000) 3.38
Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci U S A (2000) 3.38
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther (2012) 3.22
Randomized clinical trial of early laparoscopy in the management of acute non-specific abdominal pain. Br J Surg (1999) 3.18
Job strain in relation to body mass index: pooled analysis of 160 000 adults from 13 cohort studies. J Intern Med (2011) 3.14
Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension (1989) 3.13
Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res (1997) 3.09
Randomised studies of income supplementation: a lost opportunity to assess health outcomes. J Epidemiol Community Health (1999) 3.05
Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tob Control (2009) 3.05
China's forest policy for the 21st century. Science (2000) 3.04
Early-life determinants of overweight and obesity: a review of systematic reviews. Obes Rev (2010) 2.99
Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care (2004) 2.77
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol (1998) 2.71
Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem (2000) 2.70
Socio-economic status and blood pressure: an overview analysis. J Hum Hypertens (1998) 2.68
Lyme arthritis in the Hunter Valley. Med J Aust (1982) 2.68
Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol (2009) 2.67
Biomechanical energy harvesting: generating electricity during walking with minimal user effort. Science (2008) 2.66
Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res (2011) 2.64
Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry (2001) 2.59
Complete genome sequence of the shrimp white spot bacilliform virus. J Virol (2001) 2.58
Why is mortality higher in Scotland than in England and Wales? Decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a 'Scottish Effect'. J Public Health (Oxf) (2005) 2.58
Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ (2000) 2.57
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54
Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health (2000) 2.50
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol (1996) 2.45
Geostatistical analysis of soil contamination in the Swiss Jura. Environ Pollut (1994) 2.45
National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology. J Med Genet (2002) 2.39
The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem (2001) 2.37
The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care (2003) 2.36
Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans. J Med Virol (2002) 2.35
Why the Scots die younger: synthesizing the evidence. Public Health (2012) 2.34
Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32
By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart (2005) 2.32
Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens (1998) 2.28
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
Primary prevention of stroke. Lancet (1992) 2.27
The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes. J Cell Biol (2000) 2.26
Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A (1985) 2.26
"I don't like Mondays"-day of the week of coronary heart disease deaths in Scotland: study of routinely collected data. BMJ (2000) 2.25
Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res (1996) 2.25
Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol (2001) 2.25
Improved hypertension management and control: results from the health survey for England 1998. Hypertension (2001) 2.25
Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25